Challenges in managing cervical cancer in pregnancy: three case reports
Crabb, Katie Okwesa, Janet Kwong, Fong Lien
Crabb, Katie
Okwesa, Janet
Kwong, Fong Lien
Abstract
Cervical cancer in pregnancy is a rare but increasingly recognised condition, affecting approximately 0.1-12.0 per 10,000 pregnancies annually. Symptoms such as vaginal bleeding, discharge, dyspareunia, and pelvic pain may overlap with normal pregnancy-related changes, often leading to delayed diagnosis. Speculum and bimanual examination is essential in pregnant women presenting with vaginal bleeding. Urgent colposcopy referral (for example, in the UK through the two-week wait pathway) is essential. Management strategies depend on cancer stage, gestational age, and patient preferences. Options include pregnancy termination with immediate treatment or consideration of neoadjuvant chemotherapy during pregnancy in women who wish to postpone definitive therapies until after delivery. Pelvic lymphadenectomy for staging is considered safe prior to 22 weeks of gestation. Neoadjuvant chemotherapy is contraindicated in the first trimester but may be administered safely later in pregnancy. Serial magnetic resonance imaging is valuable for monitoring tumour progression and informing treatment plans. This case series highlights the clinical and ethical complexities in managing cervical cancer in pregnancy and underscores the importance of specialist, multidisciplinary, and individualised care. Further research is necessary to develop standardised, evidence-based guidelines for this challenging clinical scenario.
MIDER Authors
Citations
Altmetric:
Date
2025-11-09
Type
Article
Subject
Uterine Cervical Neoplasms, Chemotherapy, Pregnancy
Collections
Citation
Crabb K, Okwesa J, Yap JKW, Kwong FL. Challenges in managing cervical cancer in pregnancy: Three case reports. Case Rep Womens Health. 2025 Nov 9;48:e00765. doi: 10.1016/j.crwh.2025.e00765
Journal / Source Title
Case Reports in Women's Health
DOI
PMID
Publisher
Elsevier